Profile picture

Doctor Jaya Birgitte Rosenmeier

AstraZeneca, Gothenburg (Sweden)
Follow
Logo ESC

Contributor content

AZD0780, a novel, oral PCSK9 inhibitor with properties allowing for broad use, food-intake independency and co-administration with other lipid lowering therapies
Presentation
AZD0780, a novel, oral PCSK9 inhibitor with properties allowing for broad use, food-intake independency and co-administration with other lipid lowering therapies
Read more
Safety, tolerability, and pharmacokinetics of AZD5462, a small molecule agonist of the RXFP1 relaxin receptor
Presentation
Safety, tolerability, and pharmacokinetics of AZD5462, a small molecule agonist of the RXFP1 relaxin receptor
Read more

ESC 365 is supported by

novartis Explore sponsored resources